Risedronic acid
Also known as: Risedronate sodium
Active ingredient description
Risedronic acid is a pyridinyl bisphosphonate that binds to bone hydroxyapatite and inhibits osteoclast-mediated bone resorption. The bone turnover is reduced while the osteoblast activity and bone mineralisation is preserved.
Medicine classification
This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:
Medicines
Risedronic acid is the active ingredient of these drugs:
Germany
Spain
Australia
Hong Kong
Australia Austria Brazil Canada Cyprus
Tunisia
Spain
Cyprus
Cyprus
Italy
Brazil
Brazil
Italy
Cyprus Lithuania
Lithuania Poland
Finland Italy
Tunisia
Brazil
Brazil
Hong Kong
Ireland
Italy
Italy
Italy
Brazil
Italy
Lithuania Poland
Ireland Lithuania
Brazil
Tunisia
Italy
Italy
Italy
Italy
Poland
Risedronic acid is also found within below combination drugs:
ACARA TRIO , ACRIS COMBI , ACTONEL COMBI , ACTONEL PLUS CALCIUM & D , ATELVIA , OPTINATE PLUS CA & D , RIDATE PLUS CA & D
Product monographs
Medicine agencies around the world have authorized marketing of this active ingredient according to these medication package inserts (MPIs):
Structural formula
Unique ingredient identifier (UNII)
KM2Z91756Z - RISEDRONIC ACID
CAS registry number
105462-24-6 - risedronic acid
115436-72-1 - Sodium risedronate
SNOMED-CT
105590001 - Substance (substance)
768539002 - Risedronic acid (substance)